Teacher Retirement System Of Texas Intercept Pharmaceuticals, Inc. Transaction History

Teacher Retirement System Of Texas

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$9.99 - $18.71 $100,559 - $188,334	10,066 New	10,066 $187,000
Q1 2023 May 12, 2023	BUY	$12.53 - $21.71 $10,211 - $17,693	815 Added 8.13%	10,845 $146,000
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $116,448 - $161,583	10,030 New	10,030 $124,000
Q4 2018 Mar 04, 2019	SELL	$85.79 - $126.46 $209,756 - $309,194	-2,445 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$88.49 - $127.55 $149,371 - $215,304	-1,688 Reduced 40.84%	2,445 $309,000
Q2 2018 Aug 06, 2018	BUY	$60.0 - $85.67 $14,520 - $20,732	242 Added 6.22%	4,133 $347,000
Q1 2018 May 08, 2018	SELL	$52.72 - $67.25 $107,443 - $137,055	-2,038 Reduced 34.37%	3,891 $239,000
Q4 2017 Feb 06, 2018	BUY	$58.2 - $72.76 $345,067 - $431,394	5,929	5,929 $346,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.